Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma
Hongyan Xu, Wenjing Wang, Junlei Yin, Chengcun Song, Lin Li, Zhi Sun Department of Chemotherapy, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, People's Republic of ChinaCorrespondence: Hongyan Xu, Department of Chemotherapy, Weihai Municipal Hospital, No....
Saved in:
Main Authors: | Xu H (Author), Wang W (Author), Yin J (Author), Song C (Author), Li L (Author), Sun Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
by: Huan Wang, et al.
Published: (2022) -
Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023) -
Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II-III Esophageal Squamous Cell Carcinoma
by: Huiping Zhu MD, et al.
Published: (2022) -
Nanoparticle albumin-bound paclitaxel - first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022) -
Albumin-bound paclitaxel in solid tumors: clinical development and future directions
by: Kundranda MN, et al.
Published: (2015)